Picture of Albert Labs International logo

ABRT Albert Labs International Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m+42.01%
3m+24.77%
6m-44.9%
1yr-64.09%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-86.25%
50d MA+8.91%
200d MA-35.1%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-2862.74%
Return on Equityn/a
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Albert Labs International EPS forecast chart

Profile Summary

Albert Labs International Corp. is a Canada-based pharmaceutical drug development company. The Company is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The Company focuses on treating patients with urgent and unmet mental health needs, starting with cancer-related anxiety. It is also focused on improving patient access to psychedelic-assisted therapies. The Company has an asset-light business model, leveraging existing clinical infrastructure and patient pools by collaborating with research institutions, medical centers and reimbursement networks. The Company uses an accelerated pathway, Real-World Evidence (RWE) studies, to provide access to patients in need. The Company also provides in-house lab results in formulation.

Directors

    Last Annual
    December 31st, 2021
    Last Interim
    September 30th, 2022
    Incorporated
    October 16th, 2009
    Public Since
    April 29th, 2010
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    ca flag iconCanadian Securities Exchange
    Shares in Issue
    73,530,035
    Blurred out image of a map
    Address
    204 , 6321 King George Blvd, SURREY, V6E 2M4
    Web
    http://www.meresourcecorp.com/
    Phone
    +1 6048937033
    Auditors
    Dale Matheson Carr-Hilton LaBonte LLP

    ABRT Share Price Performance

    Upcoming Events for ABRT

    Similar to ABRT

    Picture of Algernon Pharmaceuticals logo

    Algernon Pharmaceuticals

    ca flag iconCanadian Securities Exchange

    Picture of Alpha Cognition logo

    Alpha Cognition

    ca flag iconCanadian Securities Exchange

    Picture of Asep Medical Holdings logo

    Asep Medical Holdings

    ca flag iconCanadian Securities Exchange

    Picture of Avisa Diagnostics logo

    Avisa Diagnostics

    ca flag iconCanadian Securities Exchange

    Picture of BetterLife Pharma logo

    BetterLife Pharma

    ca flag iconCanadian Securities Exchange

    FAQ

    Or unlock with your email

    Or unlock with your email

    0